FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hikma Pharmaceuticals USA Inc. to market a buprenorphine generic product under ANDA 078633.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Pain

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)